Literature DB >> 8504505

Increased left ventricular mass after thoracotomy and pericardiotomy. A role for relief of pericardial constraint?

M D Tischler1, M Rowan, M M LeWinter.   

Abstract

BACKGROUND: Myocardial stretch and increased ventricular filling can lead to increased rates of myocardial protein synthesis. In animal studies, left ventricular mass increases after pericardiectomy, suggesting relief of a biologically meaningful restraining role and a resultant stimulus for growth. The present study was designed to test the hypothesis that combined thoracotomy and pericardiotomy leads to left ventricular hypertrophy in patients with normal left ventricular ejection fraction undergoing elective bypass surgery. METHODS AND
RESULTS: Twenty-five patients with normal left ventricular ejection fraction without active myocardial ischemia underwent Doppler and quantitative two-dimensional echocardiography 1 day before and 6 weeks and 7 months after elective coronary artery bypass surgery. The pericardium was left widely incised in all patients. Left ventricular end-systolic volume, end-diastolic volume, stroke volume, ejection fraction, end-systolic circumferential wall stress, and mass were measured. Left ventricular end-diastolic volume index increased from 51 +/- 11 mL/m2 to 62 +/- 14 mL/m2 (p < 0.05) at 6 weeks and to 66 +/- 14 mL/m2 (p < 0.05 versus baseline, p = NS versus 6 weeks) at 7 months. Left ventricular mass index increased from 109 +/- 23 g/m2 to 127 +/- 24 g/m2 (p < 0.05) at 6 weeks and to 131 +/- 23 g/m2 (p < 0.05 versus baseline, p = NS versus 6 weeks) at 7 months. There were no changes in systolic or diastolic blood pressures, end-systolic circumferential wall stress, or end-systolic volume.
CONCLUSIONS: Patients with normal left ventricular ejection fraction develop increases in left ventricular end-diastolic volume and mass after coronary artery bypass surgery. These findings support the hypothesis that the increase in left ventricular end-diastolic volume associated with thoracotomy and pericardiotomy leads to myocardial growth and an increase in left ventricular mass.

Entities:  

Mesh:

Year:  1993        PMID: 8504505     DOI: 10.1161/01.cir.87.6.1921

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  10 in total

1.  Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial.

Authors:  Vasileios Karantalis; Darcy L DiFede; Gary Gerstenblith; Si Pham; James Symes; Juan Pablo Zambrano; Joel Fishman; Pradip Pattany; Ian McNiece; John Conte; Steven Schulman; Katherine Wu; Ashish Shah; Elayne Breton; Janice Davis-Sproul; Richard Schwarz; Gary Feigenbaum; Muzammil Mushtaq; Viky Y Suncion; Albert C Lardo; Ivan Borrello; Adam Mendizabal; Tomer Z Karas; John Byrnes; Maureen Lowery; Alan W Heldman; Joshua M Hare
Journal:  Circ Res       Date:  2014-02-24       Impact factor: 17.367

Review 2.  MR, CT, and PET imaging in pericardial disease.

Authors:  Peter Alter; Jens H Figiel; Thomas P Rupp; Georg F Bachmann; Bernhard Maisch; Marga B Rominger
Journal:  Heart Fail Rev       Date:  2013-05       Impact factor: 4.214

3.  Exercise unmasks distinct pathophysiologic features in heart failure with preserved ejection fraction and pulmonary vascular disease.

Authors:  Thomas M Gorter; Masaru Obokata; Yogesh N V Reddy; Vojtech Melenovsky; Barry A Borlaug
Journal:  Eur Heart J       Date:  2018-08-07       Impact factor: 29.983

Review 4.  The Role of the Pericardium in Heart Failure: Implications for Pathophysiology and Treatment.

Authors:  Barry A Borlaug; Yogesh N V Reddy
Journal:  JACC Heart Fail       Date:  2019-07       Impact factor: 12.035

5.  Pericardiectomy to Treat Heart Failure With Preserved Ejection Fraction: Unrestrained Enthusiasm?

Authors:  Martin M LeWinter
Journal:  Circ Heart Fail       Date:  2017-04       Impact factor: 8.790

6.  Percutaneous Pericardial Resection: A Novel Potential Treatment for Heart Failure With Preserved Ejection Fraction.

Authors:  Barry A Borlaug; Rickey E Carter; Vojtech Melenovsky; Christopher V DeSimone; Prakriti Gaba; Ammar Killu; Niyada Naksuk; Lilach Lerman; Samuel J Asirvatham
Journal:  Circ Heart Fail       Date:  2017-04       Impact factor: 8.790

7.  A Swine Model of Percutaneous Intracoronary Ethanol Induced Acute Myocardial Infarction and Ischemic Mitral Regurgitation.

Authors:  Weiwei Shi; Bryant V McIver; Kanika Kalra; Eric L Sarin; Susan Schmarkey; Michael Duggan; Vinod H Thourani; Robert A Guyton; Muralidhar Padala
Journal:  J Cardiovasc Transl Res       Date:  2017-06-02       Impact factor: 4.132

8.  Stress Imaging in Heart Failure: Physiologic, Diagnostic, and Therapeutic Insights.

Authors:  Masaru Obokata; Barry A Borlaug
Journal:  Circ Cardiovasc Imaging       Date:  2018-05       Impact factor: 7.792

9.  Sustained Improvement in Diastolic Reserve Following Percutaneous Pericardiotomy in a Porcine Model of Heart Failure With Preserved Ejection Fraction.

Authors:  C Charles Jain; Dawn Pedrotty; Philip A Araoz; Alan Sugrue; Vaibhav R Vaidya; Deepak Padmanabhan; Shivaram P Arunachalam; Lilach O Lerman; Samuel J Asirvatham; Barry A Borlaug
Journal:  Circ Heart Fail       Date:  2021-01-22       Impact factor: 8.790

10.  Early and mid-term outcome in terms of functional and hemodynamic performance of the st. Jude regent 19-mm aortic mechanical prosthesis versus 19-mm carpentier edwards aortic biological prosthesis.

Authors:  Edvin Prifti; Massimo Bonacchi; Fadil Ademaj; Gabriele Giunti; Giampiero Esposito; Arben Baboci; Gani Bajraktari; Altin Veshti; Aurel Demiraj; Vittorio Vanini
Journal:  J Cardiothorac Surg       Date:  2015-11-06       Impact factor: 1.637

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.